TABLE 3.
Patient no. | Isolate | Percent
|
|||
---|---|---|---|---|---|
CD8− of CD3+ | CCR5+ of CD3+ CD8− | p24+ of CD3+ CD8− | CCR5+ of CD3+ CD8− p24+ | ||
435 | Uninfected | 86.1 | 5.8 | 0.4 | NAb |
1577 | 84.9 | 3.6 | 1.9 | 8.8 | |
3415 | 84.0 | 3.0 | 2.1 | 4.6 | |
1838 | Uninfected | 82.5 | 5.0 | 0.3 | NA |
5379 | 78.9 | 1.9 | 3.6 | 5.3 | |
8590 | 74.1 | 1.9 | 1.8 | 17.9 | |
1047 | Uninfected | 81.0 | 6.0 | 0.6 | NA |
314 | 80.2 | 2.1 | 2.7 | 3.1 | |
4223 | 78.5 | 2.3 | 3.5 | 3.2 | |
2112 | Uninfected | 82.5 | 6.3 | 0.5 | NA |
171 | 82.7 | 5.2 | 2.4 | 1.9 | |
1156 | 82.5 | 4.2 | 2.1 | 0.4 | |
3502 | 81.1 | 4.0 | 2.7 | 1.2 | |
2242 | Uninfected | 80.6 | 5.6 | 0.4 | NA |
1886 | 79.2 | 5.4 | 0.2 | NA | |
3700 | 78.7 | 4.4 | 1.4 | 7.0 |
See the text for details. One representative experiment is shown for each patient, corresponding to Fig. 1.
NA, not applicable.